Kiora Pharmaceuticals Inc (KPRX) stock
KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
$0.93−0.05 (-5.30%)
Close on Nov 17, 2026Market cap $4.11MP/E –Yield –
Kiora Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Kiora Pharmaceuticals's cash was $16.84M at Jun 30, 2026. For fiscal 2025 it was $17.09M, down 36.2% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $26.80M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.09M | -36.2% |
| FY2024 | Dec 31, 2024 | $26.80M | +989.7% |
| FY2023 | Dec 31, 2023 | $2.46M | -59.1% |
| FY2022 | Dec 31, 2022 | $6.01M | -23.9% |
| FY2021 | Dec 31, 2021 | $7.90M | +541.9% |
| FY2020 | Dec 31, 2020 | $1.23M | -67.8% |
| FY2019 | Dec 31, 2019 | $3.82M | -52.5% |
| FY2018 | Dec 31, 2018 | $8.05M | +2.5% |
| FY2017 | Dec 31, 2017 | $7.85M | +113.3% |
| FY2016 | Dec 31, 2016 | $3.68M | -56.3% |
| FY2015 | Dec 31, 2015 | $8.41M | +4938.4% |
| FY2014 | Dec 31, 2014 | $167.00K | -66.7% |
| FY2013 | Dec 31, 2013 | $501.17K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $16.84M | -18.5% |
| Q1 FY2026 | Mar 31, 2026 | $13.87M | -42.5% |
| Q4 FY2025 | Dec 31, 2025 | $17.09M | -36.2% |
| Q3 FY2025 | Sep 30, 2025 | $19.38M | -33.3% |
| Q2 FY2025 | Jun 30, 2025 | $20.67M | -25.7% |
| Q1 FY2025 | Mar 31, 2025 | $24.11M | -22.9% |
| Q4 FY2024 | Dec 31, 2024 | $26.80M | +989.7% |
| Q3 FY2024 | Sep 30, 2024 | $29.04M | +437.3% |
| Q2 FY2024 | Jun 30, 2024 | $27.82M | +249.7% |
| Q1 FY2024 | Mar 31, 2024 | $31.28M | +811.9% |
| Q4 FY2023 | Dec 31, 2023 | $2.46M | -59.1% |
| Q3 FY2023 | Sep 30, 2023 | $5.40M | +11.4% |
| Q2 FY2023 | Jun 30, 2023 | $7.96M | +221.2% |
| Q1 FY2023 | Mar 31, 2023 | $3.43M | -32.9% |
| Q4 FY2022 | Dec 31, 2022 | $6.01M | -23.9% |
| Q3 FY2022 | Sep 30, 2022 | $4.85M | -56.5% |
| Q2 FY2022 | Jun 30, 2022 | $2.48M | -33.2% |
| Q1 FY2022 | Mar 31, 2022 | $5.11M | -23.2% |
| Q4 FY2021 | Dec 31, 2021 | $7.90M | +541.9% |
| Q3 FY2021 | Sep 30, 2021 | $11.15M | +274.7% |
| Q2 FY2021 | Jun 30, 2021 | $3.71M | -21.7% |
| Q1 FY2021 | Mar 31, 2021 | $6.66M | +12.4% |
| Q4 FY2020 | Dec 31, 2020 | $1.23M | -67.8% |
| Q3 FY2020 | Sep 30, 2020 | $2.98M | +19.1% |
| Q2 FY2020 | Jun 30, 2020 | $4.73M | +5.0% |
| Q1 FY2020 | Mar 31, 2020 | $5.92M | +0.4% |
| Q4 FY2019 | Dec 31, 2019 | $3.82M | -52.5% |
| Q3 FY2019 | Sep 30, 2019 | $2.50M | -74.9% |
| Q2 FY2019 | Jun 30, 2019 | $4.51M | -64.3% |
| Q1 FY2019 | Mar 31, 2019 | $5.90M | +59.8% |
| Q4 FY2018 | Dec 31, 2018 | $8.05M | +2.5% |
| Q3 FY2018 | Sep 30, 2018 | $9.95M | +7.6% |
| Q2 FY2018 | Jun 30, 2018 | $12.65M | +7.1% |
| Q1 FY2018 | Mar 31, 2018 | $3.69M | -32.6% |
| Q4 FY2017 | Dec 31, 2017 | $7.85M | +113.3% |
| Q3 FY2017 | Sep 30, 2017 | $9.24M | +62.7% |
| Q2 FY2017 | Jun 30, 2017 | $11.81M | – |
| Q1 FY2017 | Mar 31, 2017 | $5.48M | – |
| Q4 FY2016 | Dec 31, 2016 | $3.68M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.68M | – |
See a number that looks wrong?